Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/1/2026

1. MU
2. SPY
3. DASH
4. BA
5. CRWV
6. CCL
7. MDB
8. PSKY
9. AMZN
10. LLY

Go back to Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 39.60 --0 (-0%)
Previous Close $39.60    52 Week High $66.55 
Open $39.60    52 Week Low $37.82 
Day High $39.60    P/E N/A 
Day Low $39.60    EPS $0.00 
Volume 3,042       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 39.60 --0 (-0%)
Previous Close $39.60    52 Week High $66.55 
Open $39.60    52 Week Low $37.82 
Day High $39.60    P/E N/A 
Day Low $39.60    EPS $0.00 
Volume 3,042